US 6951846
Artemisinins with improved stability and bioavailability for therapeutic drug development and application
expired A61KA61K31/55A61K31/724
Quick answer
US patent 6951846 (Artemisinins with improved stability and bioavailability for therapeutic drug development and application) held by The United States of America as represented by the Secretary of the Army expires Mon Sep 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army
- Grant date
- Tue Oct 04 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/55, A61K31/724, A61K47/6951